Browse: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 1 | 3 |
Wyeth Patent Law Group patentsThe following is a sampling of recent Wyeth Patent Law Group patent applications (USPTO Patent Application #, Patent Title) sorted by month.
June 2009 - Wyeth Patent Law Group patents
20090162321 - Methods for packaging propagation-defective vesicular stomatitis virus vectors using a stable cell line that expresses g protein
20090162398 - Methods and compositions for immunizing pigs against porcine circovirus
20090155353 - Microemulsions for pharmaceutical compositions
20090155784 - Assessment of asthma and allergen-dependent gene expression
20090156537 - Compositions and methods for diagnosing and treating asthma or other allergic or inflammatory diseases
20090156826 - Methods for the preparation of hydroxy-substituted aryl sulfamide compounds
20090148436 - Antibody to gdf8 and uses thereof
20090149458 - Pyrrolo[3,2-d]pyrimidine compounds and their use as pi3 kinase and mtor kinase inhibitors
20090142806 - Interleukin-17f antibodies and other il-17f signaling antagonists and uses therefor
May 2009 - Wyeth Patent Law Group patents
20090137516 - Compositions and methods of treating dyslipidemia
20090124002 - Alpha-1d calcium channel expressed in atrium
20090117152 - Mycoplasma hyopneumoniae avirulent adjuvanted live vaccine
20090118276 - Thienopyrimidines, thienopyridines, and pyrrolopyrimidines as b-raf inhibitors
April 2009 - Wyeth Patent Law Group patents
20090105294 - Biosynthetic gene cluster for the production of a complex polyketide
20090105294 - Biosynthetic gene cluster for the production of a complex polyketide
20090105294 - Biosynthetic gene cluster for the production of a complex polyketide
20090105303 - Sulfonyl-3-heterocyclylindazole derivatives as 5-hydroxytryptamine-6 ligands
20090105303 - Sulfonyl-3-heterocyclylindazole derivatives as 5-hydroxytryptamine-6 ligands
20090105303 - Sulfonyl-3-heterocyclylindazole derivatives as 5-hydroxytryptamine-6 ligands
20090105461 - Calicheamicin conjugates
20090105461 - Calicheamicin conjugates
20090105461 - Calicheamicin conjugates
20090097026 - Color measurements of reconstituted tigecycline and degradant thereof
20090098086 - Thienopyrimidine and pyrazolopyrimidine compounds and their use as mtor kinase and pi3 kinase inhibitors
20090098132 - Composition and method for treating lupus nephritis
20090098577 - Method of identifying compounds that modulate caspase 9 activity via use of a kosmotropic salt
20090099376 - Tigecycline and methods of preparing intermediates
20090092635 - Heterologous prime-boost immunization regimen
20090093498 - Amino-5,5-diphenylimidazolone derivatives for the inhibition of beta-secretase
20090087431 - Methods of treating bone disorders with modulators of axl
20090087431 - Methods of treating bone disorders with modulators of axl
20090088448 - Rapamycin derivatives and the uses thereof in the treatment of neurological disorders
20090088448 - Rapamycin derivatives and the uses thereof in the treatment of neurological disorders
March 2009 - Wyeth Patent Law Group patents
20090082354 - Pyrazolo[5, 1-c] [1,2,4] triazines, methods for preparation and use thereof
20090072189 - Method of making heat cells comprising exothermic compositions having absorbent gelling material
20090075283 - Vectors and methods for cloning gene clusters or portions thereof
20090075839 - Novel streptococcus pneumoniae open reading frames encoding polypeptide antigents and uses thereof
20090076077 - Methods and compositions for selectin inhibition
20090068231 - Live attenuated mycoplasma strains
20090068232 - Attenuated mycoplasma gallisepticum strains
20090069300 - Isoquinolinyl and isoindolinyl derivatives as histamine-3 antagonists
20090069319 - Imidazopyridine analogs and their use as agonists of the wnt-beta-catenin cellular messaging system
20090069342 - Kv1.5 potassium channel inhibitors
20090069370 - Azacyclylisoquinolinone and isoindolinone derivatives as histamine-3 antagonists
20090069564 - Methods and compositions for selectin inhibition
20090060952 - Production of the lipidated form of the peptidoglycan-associated liproproteins of gram-negative bacteria
20090061024 - Compositions and methods employing nmda antagonists for achieving an anesthetic-sparing effect
20090061423 - Pharmacogenomic markers for prognosis of solid tumors
20090062131 - Nucleic acid arrays for detecting gene expression in animal models of inflammatory diseases
20090062281 - 3-quinolinecarbonitrile protein kinase inhibitors
February 2009 - Wyeth Patent Law Group patents
20090054392 - Naphthylpyrimidine, naphthylpyrazine and naphthylpyridazine analogs and their use as agonists of the wnt-beta-catenin cellular messaging system
20090054484 - Substituted heteroaryl benzofuran acids
20090047287 - Modulation of bone formation
20090048282 - Pyrimidine sulfonamide analogs and their use as agonists of the wnt-beta-catenin cellular messaging system
20090048286 - Inhibitors of protein tyrosine phosphatase 1b
20090048320 - Amino-5-[4-(difluoromethoxy)phenyl]-5-phenylimidazolone compounds for the inhibition of beta-secretase
20090042908 - Amino-5-(6-membered)heteroarylimidazolone compounds and the use thereof for beta-secretase modulation
20090042912 - Diphenylimidazolyl compounds as inhibitors of beta-secretase
20090042964 - Amino-5-[substituted-4-(difluoromethoxy)phenyl]-5-phenylimidazolone compounds as beta-secretase inhibitors
20090035807 - Analysis of polypeptide production
20090036439 - 3-aryl-4-hydroxyfuranone compounds and the human and animal health use thereof
20090036458 - Endoparasiticidal topical compositions
January 2009 - Wyeth Patent Law Group patents
20090022731 - Arthritis-associated b cell gene expression
20090022753 - Surface proteins of streptococcus pyogenes
20090023707 - Aminoalkylazole derivatives as histamine-3 antagonists
20090023925 - N'-(2-halobenzylidene)sulfonylhydrazides as intermediates in the manufacture of arylsulfonylindazoles
20090017064 - Methods and compositions for immunizing pigs against porcine circovirus
20090017067 - Emulsion vaccine compositions comprising antigen and adjuvant in the aqueous phase
20090018332 - Processes for preparing bicyclic oxazine carboxaldehyde and beta-lactamase inhibitors
20090010963 - Raccoon poxvirus expressing rabies glycoproteins
20090012095 - Human n-type calcium channel blockers
20090012139 - Amino-5-[4-(difluoromethoxy) phenyl]-5-phenylimidazolone compounds for the inhibition of beta-secretase
20090012308 - Process for the manufacture of benzylsulfonylarenes
April 2008 - Wyeth Patent Law Group patents
20080096903 - Sulfamoyl-containing derivatives and uses thereof
20080089916 - Botanical butter stick lip balm
20080090891 - Ion channel modulators
20080085890 - Substituted isoquinoline-1,3(2h,4h)-diones, 1-thioxo-1,4-dihydro-2h-isoquinoline-3-ones and 1,4-dihydro-3 (2h)-isoquinolones and methods of use thereof
20080085925 - Sulfonyltetrahydro-3h-benzo(e)indole-8-amine compounds as 5-hydroxytryptamine-6 ligands
20080085938 - Arylamino-arylpropanolamine derivatives and methods of their use
20080081366 - Polynucleotide composition, method of preparation, and use thereof
March 2008 - Wyeth Patent Law Group patents
20080076801 - Indolylalkylpyridin-2-amines for the inhibition of beta-secretase
20080070797 - Nucleic acid arrays for detecting gene expression associated with human osteoarthritis and human proteases
20080070943 - Sulfonyldihydroimidazopyridinone compounds as 5-hydroxytryptamine-6 ligands
20080071091 - Processes and compounds for the preparation of substituted naphthylindole derivatives
20080064667 - Oxazole derivatives of tetracyclines
20080064684 - 1-aryl- or 1-alkylsulfonyl-heterocyclybenzazoles as 5-hydroxytryptamine-6 ligands
February 2008 - Wyeth Patent Law Group patents
20080051390 - Imidazole amines as inhibitors of beta-secretase
20080045518 - Oxazinan-2-one derivatives useful as pr modulators
20080045556 - Oxazolidone derivatives as pr modulators
20080045560 - Pyrrolidine and related derivatives useful as pr modulators
20080045577 - Imidazolidin-2-one derivatives useful as pr modulators
20080045578 - Tricyclic oxazolidone derivatives useful as pr modulators
20080045579 - Oxazolidine derivatives as pr modulators
20080032299 - Methods for prognosis and treatment of solid tumors
20080033175 - Process for preparation of 4-amino-3-quinolinecarbonitriles
December 2007 - Wyeth Patent Law Group patents
20070292450 - Immunogenic compositions of staphylococcus epidermidis polypeptide antigens
20070286817 - Treating cystic fibrosis with antibiotics via a swirler delivery
20070286818 - Treating cystic fibrosis with antibiotics via an aerosol drug
20070281922 - 1-sulfonylindazolylamine and - amide derivatives as 5-hydroxytryptamine-6 ligands
20070281945 - Benzoxazole and benzothiazole derivatives as 5-hydroxytryptamine-6 ligands
November 2007 - Wyeth Patent Law Group patents
20070269430 - Combination therapy for the treatment of acute leukemia and myelodysplastic syndrome
20070269531 - Non-steroid anti-inflammatory agents with vitamins, minerals, and dietary supplements for the prevention and treatment of primary, secondary and tertiary cancer
20070270440 - N-benzoyl- and n-benzylpyrrolidin-3-ylamines as histamine-3 antagonists
20070258997 - Rescue of mumps virus from cdna
20070259439 - Determination of antibiotic concentration in bone
20070253972 - Rescue of mumps virus from cdna
20070253977 - Recombinant rsv strains with altered g protein
October 2007 - Wyeth Patent Law Group patents
20070249627 - Tubulin inhibitor and process for its preparation
20070244105 - Dihydro[1,4]oxazino[2,3,4-hi]indazole derivatives as 5-hydroxytryptamine-6 ligands
20070244106 - Substituted-dihydro[1,4]oxazino[2,3,4-hi]indazole derivatives as 5-hydroxytryptamine-6 ligands
20070244140 - Anilino-pyrimidine phenyl and benzothiophene analogs
20070244179 - Dihydro[1,4]dioxino[2,3-e]indazole derivatives as 5-hydroxytryptamine-6 ligands
20070238178 - Methods and compositions for inhibiting the function of polynucleotide sequences
20070238724 - Sulfonyl-3-heterocyclylindazole derivatives as 5-hydroxytryptamine-6 ligands
20070231349 - West nile vaccine
20070231350 - West nile vaccine
20070232557 - Methods and compositions for inhibiting the function of polynucleotide sequences
20070232582 - 4-substituted or unsubtituted-7-hydro-1,4-thiazepine-7-[bicyclic or tricyclic heteroaryl] substituted-3,6-dicarboxylic acid derivatives as beta-lactamase inhibitors
20070232618 - Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands
September 2007 - Wyeth Patent Law Group patents
20070218075 - Altered fibronectin-binding protein of staphylococcus aureus
20070219151 - Methods and compositions for inhibiting the function of polynucleotide sequences
20070219183 - Dihydropyrazolo[1,5-a]pyrimidine and dihydroimidazo[1,5-a]pyrimidine derivatives and methods of use thereof
20070219186 - Pyrazolo[1,5-a]pyrimidine derivatives and methods of use thereof
20070219240 - N-substituted-azacyclylamines as histamine-3 antagonists
20070219394 - Process for the synthesis of n-acyl-2-amino-4-alkoxy-5-nitrobenzoic acids
20070213511 - Calicheamicin conjugation by antibody deglycosylation
20070208084 - Enantiomers of o-desmethyl venlafaxine
August 2007 - Wyeth Patent Law Group patents
20070203116 - Dihydrospiro[dibenzo[a,d][7]annulene-5,4'-imidazol] compounds for the inhibition of beta-secretase
20070197455 - Processes for the convergent synthesis of calicheamicin derivatives
20070197661 - Phenylephrine liquid formulations
20070190031 - Plasmid having three complete transcriptional units and immunogenic compositions for inducing an immune response to hiv
20070190060 - Passive targeting of cytotoxic agents
20070191431 - 2-amino-5-piperidinylimidazolone compounds and use thereof for beta-secretase modulation
20070178119 - West nile vaccine
July 2007 - Wyeth Patent Law Group patents
20070166324 - West nile vaccine
20070166325 - West nile vaccine
20070166326 - West nile vaccine
20070166802 - West nile vaccine
20070167431 - Method for the treatment of cognitive dysfunction
20070161550 - Antiviral compositions which inhibit paramyxovirus infection
20070155834 - Acetylenic aryl sulfonate hydroxamic acid tace and matrix metalloproteinase inhibitors
June 2007 - Wyeth Patent Law Group patents
20070134269 - Mycoplasma hyopneumoniae bacterin vaccine
20070128222 - Fusogenic, self-propagating blebs as immunogenic compositions
20070128239 - Benzimidazole non-aqueous compositions
May 2007 - Wyeth Patent Law Group patents
20070122433 - Formulations of hydrophobic proteins in an immunogenic composition having improved tolerability
20070117794 - Methods of treatment using oxytocin receptor agonists
20070117870 - Enantiomers of n-desmethyl venlafaxine
20070104739 - Equine protozoal myeloencephalitis vaccine
20070099911 - Pyrroloquinolinone derivatives as 5-hydroxytryptamine-6 ligands
20070099912 - Pyrrolo[2,3-f] and [3,2-f]isoquinolinone derivatives as 5-hydroxytryptamine-6 ligands
April 2007 - Wyeth Patent Law Group patents
20070092537 - Compositions and methods for the treatment of canine influenza virus disease
March 2007 - Wyeth Patent Law Group patents
20070049564 - 9-aminocarbonylsubstituted derivatives of glycylcyclines
February 2007 - Wyeth Patent Law Group patents
20070037802 - Substituted-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands
20070037884 - Novel succinate salt of o-desmethyl-venlafaxine
20070031450 - Stabilizers for veterinary vaccines
20070025959 - Adjuvant combination formulations
20070026080 - Manufacturing process for tigecycline
20070027199 - Cycloalkyl amino-hydantoin compounds and use thereof for beta-secretase modulation
January 2007 - Wyeth Patent Law Group patents
20070020296 - Mycoplasma hyopneumoniae bacterin vaccine
20070004730 - Amino-5-(6-membered)heteroarylimidazolone compounds and the use thereof for beta-secretase modulation
20070004786 - Amino-5-(5-membered)hetero-arylimidazolone compounds and the use thereof for beta-secretase modulation
December 2006 - Wyeth Patent Law Group patents
20060288955 - Device and method for controlling insects
20060293260 - Useful high load concentrate compositions for control of ecto-and endo-parasites
20060281760 - Tubulin inhibitor and process for its preparation
20060281943 - Stereoselective synthesis of (e)-vinylboronic esters via a zr mediated hydroboration of alkynes
20060276445 - Bicyclic 6-alkylidene-penems as class-d beta-lactamases inhibitors
20060276446 - Tricyclic 6-alkylidene-penems as class-d beta-lactamases inhibitors
20060276498 - 4,6-diamino-[1,7]naphthyridine-3-carbonitrile inhibitors of tpl2 kinase and methods of making and using the same
November 2006 - Wyeth Patent Law Group patents
20060269584 - Gel compositions for control of ecto-parasites
20060269585 - Versatile high load concentrate compositions for control of ecto- parasites
20060269910 - Assay methods for detection of a virus in an avian tissue sample
20060270638 - Delivery of tigecycline in the presence of warfarin
20060270677 - Method for the treatment of noise phobia in companion animals
20060264460 - 3-cyanoquinoline inhibitors of tpl2 kinase and methods of making and using the same
20060251675 - Mutant cholera holotoxin as an adjuvant and an antigen carrier protein
20060251705 - Delivery of tigecycline in the presence of heparin
20060247217 - Tricyclic protein kinase inhibitors
October 2006 - Wyeth Patent Law Group patents
20060241306 - Process for the synthesis of functionalized indolizidines
20060235046 - Use of an epidermal growth factor receptor kinase inhibitor (egfr) in gefitinib resistant patients
20060228373 - Mycoplasma hyopneumoniae bacterin vaccine
20060228380 - Multivalent pneumococcal polysaccharide-protein conjugate composition
20060228381 - Separation of contaminants from streptococcus pneumoniae polysaccharide by ph manipulation
20060222660 - Use of dna vaccine in combination with a conventional vaccine to overcome immunogen interference
###
This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Wyeth Patent Law Group in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Wyeth Patent Law Group with additional patents listed. Browse our Agent directory for other possible listings.
###
FreshPatents.com Support
|
REGISTER now for FREE 
